miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase

Human Molecular Genetics

Volumn 24, Issue 9, 2015, Pages 2539-2551

  Qu, Hongxia ^a   Zheng, Liduan ^a   Pu, Jiarui ^a   Mei, Hong ^a   Xiang, Xuan ^a   Zhao, Xiang ^a   Li, Dan ^a   Li, Shiwang ^a   Mao, Ling ^a   Huang, Kai ^a   Tong, Qiangsong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 1 PROTEIN; HEPARANASE; HISTONE H3; MICRORNA; MICRORNA 145; MIRNA 558; RNA POLYMERASE II; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; ARGONAUTE PROTEIN; BETA GLUCURONIDASE; EIF2C1 PROTEIN, HUMAN; INITIATION FACTOR; MIRN-558 MICRORNA, HUMAN; PROTEIN BINDING;

AGGRESSIVENESS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING SITE; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISTANT METASTASIS; EPIGENETICS; GENE INTERACTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; MALE; MOUSE; NEUROBLASTOMA CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; ANIMAL; CELL PROLIFERATION; CELL TRANSFORMATION; DISEASE MODEL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); NEUROBLASTOMA; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

ANIMALS; ARGONAUTE PROTEINS; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; EUKARYOTIC INITIATION FACTORS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLUCURONIDASE; HETEROGRAFTS; HUMANS; MALE; MICRORNAS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; NEUROBLASTOMA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TUMOR BURDEN; UP-REGULATION;

EID: 84938141133     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv018     Document Type: Article

References (50)

1. Westermann, F. and Schwab, M. (2002) Genetic parameters of neuroblastomas. Cancer Lett., 184, 127-147.
2. Israel, V., Neta, I., Annamaria, N. and Benito, C. (2007) Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr. Pharm. Des., 13, 2057-2073.
3. Ramani, V.C., Purushothaman, A., Stewart, M.D., Thompson, C.A., Vlodavsky, I., Au, J.L. and Sanderson, R.D. (2013) The heparanase/ syndecan-1 axis in cancer: mechanisms and therapies. FEBS J., 280, 2294-2306.
4. Zetser, A., Bashenko, Y., Edovitsky, E., Levy-Adam, F., Vlodavsky, I. and Ilan, N. (2006) Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res., 66, 1455-1463.
5. Sato, T., Yamaguchi, A., Goi, T., Hirono, Y., Takeuchi, K., Katayama, K. and Matsukawa, S. (2004) Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis. J. Surg. Oncol., 87, 174-181.
6. Koliopanos, A., Friess, H., Kleeff, J., Shi, X., Liao, Q., Pecker, I., Vlodavsky, I., Zimmermann, A. and Büchler, M.W. (2001) Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res., 61, 4655-4659.
7. Heukamp, L.C., van der Burg, S.H., Drijfhout, J.W., Melief, C.J., Taylor-Papadimitriou, J. and Offringa, R. (2001) Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T-cell epitopes that induce protective anti-tumor immunity in HLA-A2/K(b)- transgenic mice. Int. J. Cancer, 91, 385-392.
8. Takaoka, M., Naomoto, Y., Ohkawa, T., Uetsuka, H., Shirakawa, Y., Uno, F., Fujiwara, T., Gunduz, M., Nagatsuka, H., Nakajima, M. et al. (2003) Heparanase expression correlates with invasion and poor prognosis in gastric cancers. Lab. Invest., 83, 613-622.
9. Shinyo, Y., Kodama, J., Hongo, A., Yoshinouchi, M. and Hiramatsu, Y. (2003) Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer. Ann. Oncol., 14, 1505-1510.
10. Zheng, L.D., Tong, Q.S., Tang, S.T., Du, Z.Y., Liu, Y., Jiang, G.S. and Cai, J.B. (2009) Expression and clinical significance of heparanase in neuroblastoma. World J. Pediatr., 5, 206-210.
11. Jiang, G., Zheng, L., Pu, J., Mei, H., Zhao, J., Huang, K., Zeng, F. and Tong, Q. (2012) Small RNAs targeting transcription start site induce heparanase silencing through interference with transcription initiation in human cancer cells. PLoS ONE, 7, e31379.
12. Zheng, L., Jiang, G., Mei, H., Pu, J., Dong, J., Hou, X. and Tong, Q. (2010) Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells. BMC Cancer, 10, 33.
13. Mei, H., Lin, Z.Y. and Tong, Q.S. (2014) The roles of microRNAs in neuroblastoma. World J. Pediatr., 10, 10-16.
14. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
15. Tay, Y., Zhang, J., Thomson, A.M., Lim, B. and Rigoutsos, I. (2008) MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature, 455, 1124-1128.
16. Zhang, L., Sullivan, P.S., Goodman, J.C., Gunaratne, P.H. and Marchetti, D. (2011) MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase. Cancer Res., 71, 645-654.
17. Place, R.F., Li, L.C., Pookot, D., Noonan, E.J. and Dahiya, R. (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl Acad. Sci. USA, 105, 1608-1613.
18. Younger, S.T. and Corey, D.R. (2011) Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters. Nucleic Acids Res., 39, 5682-5691.
19. Tan, Y., Zhang, B., Wu, T., Skogerbo, G., Zhu, X., Guo, X., He, S. and Chen, R. (2009) Transcriptional inhibiton of Hoxd4 expression by miRNA-10a in human breast cancer cells. BMC Mol. Biol., 10, 12.
20. Kim, D.H., Sætrom, P., Snøve, O. and Rossi, J.J. (2008) Micro-RNA-directed transcriptional gene silencing in mammalian cells. Proc. Natl Acad. Sci. USA, 105, 16230-16235.
21. Piriyapongsa, J., Bootchai, C., Ngamphiw, C. and Tongsima, S. (2012) microPIR: an integrated database of microRNA target sites within human promoter sequences. PLoS ONE, 7, e33888.
22. Shohet, J.M., Ghosh, R., Coarfa, C., Ludwig, A., Benham, A.L., Chen, Z., Patterson, D.M., Barbieri, E., Mestdagh, P., Sikorski, D.N. et al. (2011) A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma. Cancer Res., 71, 3841-3851.
23. Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D. and Semenza, G.L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol., 16, 4604-4613.
24. Li, L.C., Okino, S.T., Zhao, H., Pookot, D., Place, R.F., Urakami, S., Enokida, H. and Dahiya, R. (2006) Small dsRNAs induce transcriptional activation in human cells. Proc. Natl Acad. Sci. USA, 103, 17337-17342.
25. Huang, V., Place, R.F., Portnoy, V.,Wang, J., Qi, Z., Jia, Z., Yu, A., Shuman, M., Yu, J. and Li, L.C. (2012) Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res., 40, 1695-1707.
26. Dong, J., Kukula, A.K., Toyoshima, M. and Nakajima, M. (2000) Genomic organization and chromosome localization of the newly identifiedhuman heparanase gene. Gene, 253, 171-178.
27. Jiang, P., Kumar, A., Parrillo, J.E., Dempsey, L.A., Platt, J.L., Prinz, R.A. and Xu, X. (2002) Cloning and characterization of the human heparanase-1 (HPR1) gene promoter: role of GA-binding protein and Sp1 in regulating HPR1 basal promoter activity. J. Biol. Chem., 277, 8989-8998.
28. Lu,W.C., Liu, Y.N., Kang, B.B. and Chen, J.H. (2003) Trans-activation of heparanase promoter by ETS transcription factors. Oncogene, 22, 919-923.
29. Ogishima, T., Shiina, H., Breault, J.E., Tabatabai, L., Bassett,W. W., Enokida, H., Li, L.C., Kawakami, T., Urakami, S., Ribeiro-Filho, L.A. et al. (2005) Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Clin. Cancer Res., 11, 1028-1036.
30. Cohen, I., Pappo, O., Elkin, M., San, T., Bar-Shavit, R., Hazan, R., Peretz, T., Vlodavsky, I. and Abramovitch, R. (2006) Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int. J. Cancer, 118, 1609-1617.
31. Baraz, L., Haupt, Y., Elkin, M., Peretz, T. and Vlodavsky, I. (2006) Tumor suppressor p53 regulates heparanase gene expression. Oncogene, 25, 3939-3947.
32. Janowski, B.A., Younger, S.T., Hardy, D.B., Ram, R., Huffman, K.E. and Corey, D.R. (2007) Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat. Chem. Biol., 3, 166-173.
33. Nishi, K., Nishi, A., Nagasawa, T. and Ui-Tei, K. (2013) Human TNRC6A is an Argonaute-navigator protein for microRNA-mediated gene silencing in the nucleus. RNA, 19, 17-35.
34. Peters, L. and Meister, G. (2007) Argonaute proteins: mediators of RNA silencing. Mol. Cell, 26, 611-623.
35. Younger, S.T., Pertsemlidis, A. and Corey, D.R. (2009) Predicting potential miRNA target sites within gene promoters. Bioorg. Med. Chem. Lett., 19, 3791-3794.
36. Liao, J.Y., Ma, L.M., Guo, Y.H., Zhang, Y.C., Zhou, H., Shao, P., Chen, Y.Q. and Qu, L.H. (2010) Deep sequencing of human nuclear and cytoplasmic small RNAs reveals an unexpectedly complex subcellular distribution of miRNAs and tRNA 3' trailers. PLoS ONE, 5, e10563.
37. Majid, S., Dar, A.A., Saini, S., Yamamura, S., Hirata, H., Tanaka, Y., Deng, G. and Dahiya, R. (2010) MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer, 116, 5637-5649.
38. Cummins, J.M., He, Y., Leary, R.J., Pagliarini, R., Diaz, L.A., Sjoblom, T., Barad, O., Bentwich, Z., Szafranska, A.E., Labourier, E. et al. (2006) The colorectal microRNAome. Proc. Natl Acad. Sci. USA, 103, 3687-3692.
39. Maes, O.C., An, J., Sarojini, H., Wu, H. and Wang, E. (2008) Changes in MicroRNA expression patterns in human fibroblasts after low-LET radiation. J. Cell Biochem., 105, 824-834.
40. Park, S.J., Cheon, E.J. and Kim, H.A. (2013) MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1ß-induced catabolic effects in human articular chondrocytes. Osteoarthritis Cartilage, 21, 981-989.
41. Si, H., Sun, X., Chen, Y., Cao, Y., Chen, S.,Wang, H. and Hu, C. (2013) Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J. Cancer Res. Clin. Oncol., 139, 223-229.
42. Toscano-Garibay, J.D. and Aquino-Jarquin, G. (2014) Transcriptional regulation mechanism mediated by miRNA-DNA•DNA triplex structure stabilized by Argonaute. Biochim. Biophys. Acta., 1839, 1079-1083.
43. Zhang, H., Qi, M., Li, S., Qi, T., Mei, H., Huang, K., Zheng, L. and Tong, Q. (2012) MicroRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells. Mol. Cancer Ther., 11, 1454-1466.
44. Zhang,H., Pu, J., Qi, T., Qi, M., Yang,C., Li, S.,Huang, K., Zheng, L. and Tong, Q. (2014) MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha. Oncogene, 33, 387-397.
45. Li, D., Mei, H., Qi, M., Yang, D., Zhao, X., Xiang, X., Pu, J., Huang, K., Zheng, L. and Tong, Q. (2013) FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma. Oncotarget, 4, 2021-2044.
46. Zheng, L., Pu, J., Qi, T., Qi, M., Li, D., Xiang, X., Huang, K. and Tong, Q. (2013) miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells. Mol. Cancer Res., 11, 182-193.
47. Zheng, L., Qi, T., Yang, D., Qi, M., Li, D., Xiang, X., Huang, K. and Tong, Q. (2013) microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1. PLoS ONE, 8, e55719.
48. Griffiths-Jones, S. (2004) The microRNA registry. Nucleic Acids Res., 32, D109-D111.
49. Zheng, L., Li, D., Xiang, X., Tong, L., Qi, M., Pu, J., Huang, K. and Tong, Q. (2013) Methyl jasmonate abolishes the migration, invasion and angiogenesis of gastric cancer cells through downregulation of matrix metalloproteinase 14. BMC Cancer, 13, 74.
50. Lin, C.W., Chang, Y.L., Chang, Y.C., Lin, J.C., Chen, C.C., Pan, S.H., Wu,C.T., Chen,H.Y.,Yang, S.C., Hong,T.M. et al. (2013) MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat. Commun., 4, 1877.